Navigation Links
New Sackler Institute and Chair for Translational Neurodevelopment at King's College London
Date:7/25/2013

King's College London has received a transformative gift from the Dr. Mortimer and Theresa Sackler Foundation to establish the Dr. Mortimer D. Sackler Chair in Translational Neurodevelopment and the Sackler Institute for Translational Neurodevelopment.

As a result of this gift we are delighted to announce that Professor Declan Murphy, Head of the Department of Forensic and Neurodevelopmental Science at the Institute of Psychiatry (IoP) at King's has been appointed the Dr. Mortimer D. Sackler Chair in Translational Neurodevelopment and will lead the new Institute.

The Sackler Institute for Translational Neurodevelopment aims to transform our understanding of how disorders such as autism spectrum disorder, epilepsy and Down's syndrome develop over a lifespan, to improve diagnostic approaches and to develop innovative treatments for these disorders.

King's has an established reputation in neurodevelopmental research and the creation of the Sackler Institute for Translational Neurodevelopment will allow for greater collaboration between research teams across King's and drive the translation of findings into patient benefit.

Based at Institute of Psychiatry at King's the new Sackler Institute aims to:

  • Advance our understanding of the origin, biological mechanism and lifespan evolution of challenging neurodevelopmental disorders
  • Develop and evaluate novel diagnostic and treatment biomarkers to create individualised medicine
  • Discover and test novel psychopharmacologic, behavioural and bioengineering interventions
  • Pioneer genetic and cell therapies and offer state-of-the-art genetic counselling
  • Foster interdisciplinary research training of postdoctoral students and clinicians

Professor Sir Rick Trainor, Principal of King's College London says: "We are hugely honoured and grateful to the Sackler Foundation for this gift. Improving our understanding of neurological disorders and developing treatments for them, are central pillars of King's research. This major gift will allow us to harness this expertise and translate and expedite discoveries into patient care."

Dame Theresa Sackler of the Dr. Mortimer and Theresa Sackler Foundation, says: "We are delighted to hear that Professor Declan Murphy has been appointed the Dr. Mortimer D. Sackler Chair in Translational Neurodevelopment and we wish Professor Murphy and his team of scientists great success in challenging and resolving Neurodevelopmental disorders in their work at The Sackler Institute for Translational Neurodevelopment at King's."

Professor Shitij Kapur, Dean and Head of School of the IoP at King's says: "We are very grateful to the Sackler Foundation for their generous donation and honoured that this exciting new centre will be based at the IoP. We are delighted to appoint Professor Murphy as the Dr. D Mortimer Sackler Chair in Translational Neurodevelopment. He is a world leader in this field and is reaching out to some of the most distinguishing scientists at King's to develop the Sackler Institute faculty. This will help attract the best minds to work on innovative solutions to complex problems."

Professor Declan Murphy, Dr. D Mortimer Sackler Chair in Translational Neurodevelopment and Head of the Department of Forensic and Neurodevelopmental Science at the IoP at King's, says: "I am honoured to have been offered this position. I look forward to working with colleagues across King's, other Sackler Centres and international networks to translate new findings from basic science into treatment advances."

The Sackler Institute for Translational Neurodevelopment will become the fourth Sackler Institute in the UK, and the second at King's, joining the Sackler Institute of Pulmonary Pharmacology.


'/>"/>

Contact: Seil Collins
seil.collins@kcl.ac.uk
44-207-848-5377
King's College London
Source:Eurekalert

Related medicine news :

1. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
2. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
3. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
4. A North American first at the Montreal Heart Institute
5. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
6. Data release from the Allen Institute for Brain Science expands online atlas offerings
7. Los Robles Hospital’s Annual Health Fair Attended by Khanna Institute
8. Patient Experience Regional Roundtables Announced by The Beryl Institute
9. Stanford Woods Institute for the Environment announces 2012 Environmental Venture Project awards
10. Aetna Institute Designates RSC New England Center of Excellence
11. To tackle health cares thorniest problems, 400 health researchers form new U-M-based institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: